- Delivering Pan India
Antid® (Recombinant Anti-D Immunoglobulin) Recombinant anti-Rho(D) immunoglobulin 300 mcg/1 mL injection by Bharat Serums and Vaccines. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Recombinant anti-Rho(D) immunoglobulin 300 mcg/1 mL |
|---|---|
| Manufacturer | Bharat Serums and Vaccines |
| Country | India |
| Pack size | Recombinant anti-Rho(D) immunoglobulin 300 mcg/1 mL: 1 vial / carton |
| Storage | Store as per carton and leaflet; original sealed pack |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Antid® (Recombinant Anti-D Immunoglobulin) Recombinant anti-Rho(D) immunoglobulin 300 mcg/1 mL Injection — Anti-D (Rho) Immunoglobulin 300 mcg/mL: A Sourcing Guide for Hospitals and Pharmacies
Antid® is a brand of recombinant anti-Rho(D) immunoglobulin injection 300 mcg/1 mL for intramuscular use, marketed by Bharat Serums and Vaccines. According to the US prescribing information for Rh(D) immune globulin (Rhophylac®), such products are indicated for suppression of Rh isoimmunization in Rh(D)-negative persons and for immune thrombocytopenic purpura in Rh(D)-positive persons. The approved Indian indications of Antid are those on its pack insert. The decision to prescribe recombinant anti-d immunoglobulin, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Antid® (recombinant anti-d immunoglobulin) Recombinant anti-Rho(D) immunoglobulin 300 mcg/1 mL injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the blood medicines category. Supply is in bulk/wholesale quantities only.
Antid contains recombinant anti-Rho(D) immunoglobulin 300 mcg in 1 mL as a liquid injection for intramuscular use only, as printed on the carton.
How it works, according to the label: The reference label describes Rh(D) immune globulin as suppressing the immune response of Rh(D)-negative persons to Rh(D)-positive red blood cells.
The current US prescribing information for RHOPHYLAC® (Rh(D) immune globulin, human), a reference product of the same class (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Antid pack insert.
No trial specific to this product is cited on this page. The reference label for the product class summarises clinical studies in Rh isoimmunization suppression. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Recombinant anti-Rho(D) immunoglobulin 300 mcg/1 mL | Liquid injection for intramuscular use | 1 vial / carton |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for obstetric hospitals, pharmacists and pharmacies that source biologic products. Rh immune globulin is prescribed and supervised by a physician, as described in the prescribing information.
The Rhophylac label lists, as most common adverse reactions in suppression of Rh isoimmunization (0.5% or more), nausea, dizziness, headache, injection-site pain and malaise. It describes hemolysis in ITP use and hypersensitivity reactions. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Antid carton and leaflet. For reference, the US Rhophylac label describes refrigeration at 2°C to 8°C in the original carton, protected from light. Keep out of reach of children.
Antid is marketed by Bharat Serums and Vaccines. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Antid through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Antid available in India?
A.K. Pharma supplies Antid (recombinant anti-d immunoglobulin) Recombinant anti-Rho(D) immunoglobulin 300 mcg/1 mL injection to hospitals and pharmacies in India. Contact us for current availability.
What does Antid contain?
Recombinant anti-Rho(D) immunoglobulin 300 mcg/mL liquid injection, for intramuscular use only.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Antid be stored?
Follow the carton; the US reference label describes 2°C to 8°C in the original carton.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
